225 related articles for article (PubMed ID: 31020627)
1. Incidence and risk of major adverse cardiovascular events in middle-aged patients with chronic kidney disease: a population-based cohort study.
Chen S; Hsu WY; Lin YN; Wang CY; Wu CH; Chang KH
Int Urol Nephrol; 2019 Jul; 51(7):1219-1227. PubMed ID: 31020627
[TBL] [Abstract][Full Text] [Related]
2. Incidence and risk of major heart diseases in middle-aged adults with moderate to severe vision impairment: a population-based cohort study.
Hsueh CM; Wey JH; Yeh JS; Wu CH; Liou TH; Chang KH
Br J Ophthalmol; 2019 Aug; 103(8):1054-1059. PubMed ID: 30201734
[TBL] [Abstract][Full Text] [Related]
3. A comparison between angiotensin converting enzyme inhibitors and angiotensin receptor blockers on end stage renal disease and major adverse cardiovascular events in diabetic patients: a population-based dynamic cohort study in Taiwan.
Wu LS; Chang SH; Chang GJ; Liu JR; Chan YH; Lee HF; Wen MS; Chen WJ; Yeh YH; Kuo CT; See LC
Cardiovasc Diabetol; 2016 Apr; 15():56. PubMed ID: 27039185
[TBL] [Abstract][Full Text] [Related]
4. Dialysis Requirement and Long-Term Major Adverse Cardiovascular Events in Patients with Chronic Kidney Disease and Superimposed Acute Kidney Injury.
Omotoso BA; Turgut F; Abdel-Rahman EM; Xin W; Ma JZ; Scully KW; Arogundade FA; Balogun RA
Nephron; 2017; 136(2):95-102. PubMed ID: 28249270
[TBL] [Abstract][Full Text] [Related]
5. On-treatment lipid profiles to predict the cardiovascular outcomes in ASCVD patients comorbid with chronic kidney disease - The multi-center T-SPARCLE registry study.
Ho LT; Lin FJ; Tseng WK; Yin WH; Wu YW; Li YH; Yeh HI; Chen JW; Wu CC;
J Formos Med Assoc; 2018 Sep; 117(9):814-824. PubMed ID: 29945742
[TBL] [Abstract][Full Text] [Related]
6. Effect of spironolactone on the risks of mortality and hospitalization for heart failure in pre-dialysis advanced chronic kidney disease: A nationwide population-based study.
Tseng WC; Liu JS; Hung SC; Kuo KL; Chen YH; Tarng DC; Hsu CC
Int J Cardiol; 2017 Jul; 238():72-78. PubMed ID: 28363684
[TBL] [Abstract][Full Text] [Related]
7. Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort.
Simon TG; Roelstraete B; Hagström H; Sundström J; Ludvigsson JF
Gut; 2022 Sep; 71(9):1867-1875. PubMed ID: 34489307
[TBL] [Abstract][Full Text] [Related]
8. Major Adverse Cardiovascular Events in Antidepressant Users Within Patients With Ischemic Heart Diseases: A Nationwide Cohort Study.
Kim JH; Song YK; Jang HY; Shin JY; Lee HY; Ahn YM; Oh JM; Kim IW
J Clin Psychopharmacol; 2020; 40(5):475-481. PubMed ID: 32796394
[TBL] [Abstract][Full Text] [Related]
9. Increased Risk of Chronic Kidney Disease in Rheumatoid Arthritis Associated with Cardiovascular Complications - A National Population-Based Cohort Study.
Chiu HY; Huang HL; Li CH; Chen HA; Yeh CL; Chiu SH; Lin WC; Cheng YP; Tsai TF; Ho SY
PLoS One; 2015; 10(9):e0136508. PubMed ID: 26406879
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor-23 and cardiovascular events in CKD.
Scialla JJ; Xie H; Rahman M; Anderson AH; Isakova T; Ojo A; Zhang X; Nessel L; Hamano T; Grunwald JE; Raj DS; Yang W; He J; Lash JP; Go AS; Kusek JW; Feldman H; Wolf M;
J Am Soc Nephrol; 2014 Feb; 25(2):349-60. PubMed ID: 24158986
[TBL] [Abstract][Full Text] [Related]
11. Frequency of Early Predialysis Nephrology Care and Postdialysis Cardiovascular Events.
Yang JY; Huang JW; Chen L; Chen YY; Pai MF; Tung KT; Peng YS; Hung KY
Am J Kidney Dis; 2017 Aug; 70(2):164-172. PubMed ID: 28262267
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular and Renal Morbidity in Takayasu Arteritis: A Population-Based Retrospective Cohort Study From the United Kingdom.
Goel R; Chandan JS; Thayakaran R; Adderley NJ; Nirantharakumar K; Harper L
Arthritis Rheumatol; 2021 Mar; 73(3):504-511. PubMed ID: 32969145
[TBL] [Abstract][Full Text] [Related]
13. Migraine and subsequent chronic kidney disease risk: a nationwide population-based cohort study.
Weng SC; Wu CL; Kor CT; Chiu PF; Wu MJ; Chang CC; Tarng DC
BMJ Open; 2017 Dec; 7(12):e018483. PubMed ID: 29284721
[TBL] [Abstract][Full Text] [Related]
14. Impact of chronic kidney disease in early invasive versus early conservative revascularization strategies in non-ST-segment elevation acute coronary syndromes: a population-based study from NHIRD of Taiwan.
Chu CY; Su HM; Hsu PC; Lee WH; Lin TH; Voon WC; Lai WT; Sheu SH
Nephron Clin Pract; 2013; 124(1-2):38-46. PubMed ID: 24080763
[TBL] [Abstract][Full Text] [Related]
15. Increased long-term risk of major adverse cardiovascular events in patients with carbon monoxide poisoning: A population-based study in Taiwan.
Wong CS; Lin YC; Sung LC; Chen TT; Ma HP; Hsu YH; Tsai SH; Lin YF; Wu MY
PLoS One; 2017; 12(4):e0176465. PubMed ID: 28441428
[TBL] [Abstract][Full Text] [Related]
16. Risk of chronic kidney disease in patients with kidney stones-a nationwide cohort study.
Chuang TF; Hung HC; Li SF; Lee MW; Pai JY; Hung CT
BMC Nephrol; 2020 Jul; 21(1):292. PubMed ID: 32698782
[TBL] [Abstract][Full Text] [Related]
17. Coexistence of Metabolic Dysfunction-Associated Fatty Liver Disease and Chronic Kidney Disease Is a More Potent Risk Factor for Ischemic Heart Disease.
Miyamori D; Tanaka M; Sato T; Endo K; Mori K; Mikami T; Hosaka I; Hanawa N; Ohnishi H; Furuhashi M
J Am Heart Assoc; 2023 Jul; 12(14):e030269. PubMed ID: 37421273
[TBL] [Abstract][Full Text] [Related]
18. Impact of Skeletal Muscle Mass on Long-Term Adverse Cardiovascular Outcomes in Patients With Chronic Kidney Disease.
Harada K; Suzuki S; Ishii H; Aoki T; Hirayama K; Shibata Y; Negishi Y; Sumi T; Kawashima K; Kunimura A; Shimbo Y; Tatami Y; Kawamiya T; Yamamoto D; Morimoto R; Yasuda Y; Murohara T
Am J Cardiol; 2017 Apr; 119(8):1275-1280. PubMed ID: 28215411
[TBL] [Abstract][Full Text] [Related]
19. Infection in advanced chronic kidney disease leads to increased risk of cardiovascular events, end-stage kidney disease and mortality.
Cheikh Hassan HI; Tang M; Djurdjev O; Langsford D; Sood MM; Levin A
Kidney Int; 2016 Oct; 90(4):897-904. PubMed ID: 27591084
[TBL] [Abstract][Full Text] [Related]
20. Effects of Atrial Fibrillation and Chronic Kidney Disease on Major Adverse Cardiovascular Events.
Ding WY; Lip GYH; Pastori D; Shantsila A
Am J Cardiol; 2020 Oct; 132():72-78. PubMed ID: 32773222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
